Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

Medtronic (NYSE:MDT) today announced three U.S. milestones expanding access to its MiniMed 780G automated insulin delivery ...

The US FDA has approved Medtronic’s 780G for use with rapid-acting insulin and with Abbott’s type 2 diabetes-specific sensor.

A new system that combines high-speed video and an artificial intelligence (AI)-powered algorithm may offer quick, no-contact screenings for high blood pressure and Type 1 or Type 2 diabetes without ...

Diabetes has long been lumped into two categories - Type 1, which often appears in childhood, or Type 2, which is associated with obesity and typically develops later in life. But scientists have ...

Type 2 diabetes, linked to insulin resistance, affects a significant portion of the American population, many undiagnosed. Pre-diabetes, also caused by insulin resistance, often progresses to Type 2 ...